Genscript Biotech Corporation

GNNSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$131,990$1,446,403$1,023,999$1,180,971
Short-Term Investments$489,195$481,647$439,330$222,233
Receivables$118,715$299,662$171,673$169,037
Inventory$31,084$53,346$59,935$44,358
Other Curr. Assets$63,994$72,053$70,013$21,363
Total Curr. Assets$834,978$2,353,111$1,764,950$1,637,962
Property Plant & Equip (Net)$602,585$750,741$646,923$492,438
Goodwill$1,336$1,356$2,547$14,151
Intangibles$13,035$18,648$23,811$51,529
Long-Term Investments$3,300,566$91,109-$423,301-$203,766
Tax Assets$27,723$16,496$15,045$5,090
Other NC Assets$498,046$155,840$516,408$235,366
Total NC Assets$4,443,291$1,034,191$781,433$594,808
Other Assets$0$0$0$0
Total Assets$5,278,269$3,387,302$2,546,383$2,232,770
Liabilities
Payables$29,838$39,959$55,755$30,176
Short-Term Debt$96,269$65,878$44,785$8,031
Tax Payable$14,739$18,127$21,975$15,846
Deferred Revenue$0$91,923$41,638$34,723
Other Curr. Liab.$166,496$278,924$381,825$375,591
Total Curr. Liab.$307,342$494,811$545,978$464,367
LT Debt$74,299$351,034$305,014$148,419
Deferred Rev, NC$0$47,962$18,177$15,535
Deferred Tax Liab, NC$5,839$5,622$8,012$7,730
Other NC Liab.$567,427$443,441$306,534$261,186
Total NC Liab.$647,565$848,137$637,737$432,870
Other Liabilities$0$0$0$0
Cap. Leases$64,514$72,772$55,112$34,859
Total Liabilities$954,907$1,342,948$1,183,715$1,139,815
Equity
Pref Stock$0$1,936,758$0$214,562
Common Stock$2,141$2,120$2,111$2,096
Retained Earnings$2,350,362-$632,226-$502,248-$557,956
AOCI-$20,556$56,870$49,573$60,775
Other Equity$1,975,434$1,929,287$1,461,105$1,333,083
Total Equity$4,321,172$1,391,079$1,010,541$1,045,992
Supplemental Information
Minority Interest$2,190$653,098$352,127$213,204
Total Liab. & Tot. Equity$5,278,269$3,387,302$2,546,383$2,232,770
Net Debt$38,578-$1,029,491-$674,200-$1,024,521